Literature DB >> 22677201

CD20+ T cell numbers are decreased in untreated HIV-1 patients and recover after HAART.

Friederike Förster1, Anuj Singla, Sunil K Arora, Reinhold E Schmidt, Roland Jacobs.   

Abstract

To elucidate if CD20(+) T cells are affected by HIV-1 infection and may have a prognostic value for the course of disease, numbers of CD20(+) T cells were determined in healthy controls, untreated and HAART-treated HIV-1 patients. Coexpression patterns of CD4, CD8, and CD38 were analysed on CD3(+)CD20(+) and CD3(+)CD20(-) T cells. We found a significant decrease of CD20(+) T cell numbers in untreated HIV-1 patients (1.4%) as compared to healthy controls (2.5%) which recovered under HAART (1.9%). Particularly, the CD8(+) T cell compartment was affected revealing significant differences between healthy controls (3.4%) and both treated (1.7%) and untreated (1.1%) patients. CD38 was expressed on a few CD20(+) T cells but preferentially on CD20(-) cells in all three groups. IFN-γ production was measured upon cell activation using PMA alone or in combination with ionomycin in order to assess functional capacities of the cells. PMA alone was much more effective in CD20(+) cells regardless of CD38 coexpression, indicating a supportive role of CD20 but not CD38 in T cell activation. Here we present data showing that CD3(+)CD20(+) T cells are decreased in untreated HIV-1 patients and normal numbers are restored under HAART. Expression of CD20 and CD38 is independently regulated on T cells. Contrary to CD38, CD20 can substitute ionophores for Ca(2+) flux in early T cell activation and also strongly amplify cell stimulation in the presence of Ca(2+) ionophores, indicating that CD20 contributes to T cell activation.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22677201     DOI: 10.1016/j.imlet.2012.05.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  4 in total

Review 1.  CD20+ T cells: an emerging T cell subset in human pathology.

Authors:  Adrian Y S Lee
Journal:  Inflamm Res       Date:  2022-08-11       Impact factor: 6.986

2.  Discovery of CD3+ CD19+ cells, a novel lymphocyte subset with a potential role in human immunodeficiency virus-Mycobacterium tuberculosis coinfection, using mass cytometry.

Authors:  Qian Li; Jun Wang; Min Zhang; Yang Tang; Hongzhou Lu
Journal:  Clin Transl Med       Date:  2021-12

3.  CD32+CD4+ T Cells Sharing B Cell Properties Increase With Simian Immunodeficiency Virus Replication in Lymphoid Tissues.

Authors:  Nicolas Huot; Philippe Rascle; Cyril Planchais; Vanessa Contreras; Caroline Passaes; Roger Le Grand; Anne-Sophie Beignon; Etienne Kornobis; Rachel Legendre; Hugo Varet; Asier Saez-Cirion; Hugo Mouquet; Beatrice Jacquelin; Michaela Müller-Trutwin
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

4.  Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.

Authors:  Stefan Gingele; Thais Langer Jacobus; Franz Felix Konen; Martin W Hümmert; Kurt-Wolfram Sühs; Philipp Schwenkenbecher; Jonas Ahlbrecht; Nora Möhn; Lars H Müschen; Lena Bönig; Sascha Alvermann; Reinhold E Schmidt; Martin Stangel; Roland Jacobs; Thomas Skripuletz
Journal:  Cells       Date:  2018-12-28       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.